JPH10508580A - Ｅおよびｐセレクチンに対するリガンドのオリゴ糖構造 - Google Patents

Ｅおよびｐセレクチンに対するリガンドのオリゴ糖構造

Info

Publication number
JPH10508580A
JPH10508580A JP8510934A JP51093496A JPH10508580A JP H10508580 A JPH10508580 A JP H10508580A JP 8510934 A JP8510934 A JP 8510934A JP 51093496 A JP51093496 A JP 51093496A JP H10508580 A JPH10508580 A JP H10508580A
Authority
JP
Japan
Prior art keywords
ligand
oligosaccharides
substantially pure
selectin
oligosaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8510934A
Other languages
English (en)
Japanese (ja)
Inventor
エルハマー，エイク・ピー
ゲン，ジェン−グオ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of JPH10508580A publication Critical patent/JPH10508580A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP8510934A 1994-09-20 1995-09-15 Ｅおよびｐセレクチンに対するリガンドのオリゴ糖構造 Pending JPH10508580A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30901294A 1994-09-20 1994-09-20
US08/309,012 1994-09-20
US43329895A 1995-05-03 1995-05-03
US08/433,298 1995-05-03
PCT/US1995/011401 WO1996009309A1 (fr) 1994-09-20 1995-09-15 Structure oligosaccharide d'un ligand de la selectine e et p

Publications (1)

Publication Number Publication Date
JPH10508580A true JPH10508580A (ja) 1998-08-25

Family

ID=26976573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8510934A Pending JPH10508580A (ja) 1994-09-20 1995-09-15 Ｅおよびｐセレクチンに対するリガンドのオリゴ糖構造

Country Status (4)

Country Link
EP (1) EP0783508A1 (fr)
JP (1) JPH10508580A (fr)
AU (1) AU3548695A (fr)
WO (1) WO1996009309A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303584B1 (en) 1996-11-20 2001-10-16 The University Of Montana Water soluble lipidated arabinogalactan
IT1289728B1 (it) * 1996-12-10 1998-10-16 Sorin Biomedica Cardio Spa Dispositivo di impianto e corredo che lo comprende
WO1999043834A2 (fr) * 1998-02-27 1999-09-02 Genetics Institute, Inc. Proteine constituant un ligand de la p-selectine et proteines de fusion tetrameriques
WO2002089819A1 (fr) * 2001-05-07 2002-11-14 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Glycoconjugues et utilisations de ceux-ci
BR0315231A (pt) 2002-10-11 2005-08-23 Yamanouchi Europ Bv Compostos com base em glicose com afinidade para p-seletina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019501A1 (fr) * 1990-06-15 1991-12-26 Cytel Corporation Mediateurs d'adherence intercellulaire
WO1992022563A1 (fr) * 1991-06-10 1992-12-23 Alberta Research Council Composes modifies de lewisa au sialyl
WO1994026760A1 (fr) * 1993-05-14 1994-11-24 Cytel Corporation ANALOGUES DE SIALYLE Lex UTILES EN TANT QU'INHIBITEURS DE L'ADHESION CELLULAIRE
US5527785A (en) * 1993-05-14 1996-06-18 The Regents Of The University Of California Selectin receptor modulating compositions

Also Published As

Publication number Publication date
EP0783508A1 (fr) 1997-07-16
AU3548695A (en) 1996-04-09
WO1996009309A1 (fr) 1996-03-28

Similar Documents

Publication Publication Date Title
AU657275B2 (en) New carbohydrate-based anti-inflammatory agents
US5143712A (en) Method of determining a site of inflammation utilizing elam-1 ligands
Tyrrell et al. Structural requirements for the carbohydrate ligand of E-selectin.
Powell et al. Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2, 6-linked sialic acids that are required for recognition.
US5876715A (en) Antibodies that bind novel carbohydrate ligands (myelorollins) that cause E-selectin dependent cell rolling, and uses thereof
AU665431B2 (en) New carbohydrate-based anti-inflammatory agents
AU658383B2 (en) Agents and methods for binding to elam-1
Yamashita et al. Urinary glycopeptides of fucosidosis.
AU8102991A (en) Intercellular adhesion mediators
Seppo et al. Synthesis of a tetravalent sialyl Lewis x glycan, a high-affinity inhibitor of L-selectin-mediated lymphocyte binding to endothelium
Sueyoshi et al. Expression of distinct fucosylated oligosaccharides and carbohydrate-mediated adhesion efficiency directed by two different alpha-1, 3-fucosyltransferases. Comparison of E-and L-selectin-mediated adhesion.
Carraway et al. Structural and functional aspects of tumor cell sialomucins
Aeed et al. Characterization of the O-linked oligosaccharide structures on P-selectin glycoprotein ligand-1 (PSGL-1)
JPH10508580A (ja) Ｅおよびｐセレクチンに対するリガンドのオリゴ糖構造
Adamany et al. A carbohydrate structural variant of MM glycoprotein (glycophorin A).
AU713078B2 (en) Synthetic multivalent sLEX containing polylactosamines and methods for use
Unger The chemistry of oligosaccharide ligands of selectins: significance for the development of new immunomodulatory medicines
SK2812000A3 (en) Synthetic divalent slex containing polylactosamines and methods for use
JP3795588B2 (ja) 動的流動系においてｅ−セレクチンに依存する細胞回転および付着を惹起する新規な炭水化物リガンド類（ミエロローリン）
Edge et al. Structure of the O-linked oligosaccharides from a major thyroid cell surface glycoprotein
Kamada et al. Poly-N-acetyllactosamines synthesized by cultured Ehrlich carcinoma cells: application of endo-β-galactosidase C for analysis of the terminal structure
Wolf et al. Inhibition of homotypic aggregation of a human Burkitt‐lymphoma cell line
Wolfe et al. Storage and Excretion of Oligosaccharides and Glycopeptides in the Gangliosidoses
Morris et al. Combined use of lectin affinity chromatography and endo‐β‐galactosidase to study polylactosamine sequences isolated from haemopoietic cell surfaces